ClaroNav news

ClaroNav Kolahi Inc, a subsidiary of ClaroNav Inc, is pleased to announce that it has received Chinese regulatory clearance from the National Medical Products Administration (NMPA) to market and sell its Navient Cranial model in China. Previously it had received NMPA approval for Navient ENT model.

Navient, an image-guided surgical navigation system, is like a GPS for the surgeon to navigate inside the patient skull. It provides three-dimensional visualization and assists surgeons wit

ClaroNav Kolahi Inc (CKI) is pleased to announce that it has received Health Canada approval for its Navient ENT and Navient Cranial as Class III medical devices. Previously both devices had been approved as Class II devices.

“Navient is one of the very few image guided navigation systems approved by Health Canada as a Class III device. Upgrading our license to a higher class demonstrates our deep commitment to product quality and safety.” said Ahmad Kolahi, CEO of CKI &ld

Guided Endodontics has gained a lot of attention over the last years. Different techniques have been found efficient when locating obliterated canals. Dynamic Navigation is a great option which can help us reduce the time needed to carry out guided Endodontics procedures. It also offers many advantages when performing complex Endodontics microsurgery. This lecture is intended to help us understand the positive impact that dynamic navigation may have on our daily practice.

ClaroNav announced today that it has obtained Health Canada and CE Mark approvals to expand the indications for use of its dental navigation system, Navident, to include guiding any dental procedure. In the past, Navident, like other dental navigation systems, was limited for use in guiding the placement of dental implants. This is the first time a dental dynamic navigation system has been approved for such wide usage. What enabled this approval was a set of innovations ClaroNav introduced in

ClaroNav, an innovator in surgical navigation technology, announced today that it closed its first external equity financing round following five years of strong growth. The company plans to use these funds to continue to innovate and expand global marketing, training, sales and support activities for its flagship Navident product. Navident is a dental na